Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in DYAI — Dyadic International Inc

CIK 1214717 BOSTON, MA
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$225,813
-$31,262 QoQ
Shares Held
250,905
-20.0% QoQ
Ownership
0.689%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 39 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. DYAI ranks #394 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in DYAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $225,813 250,905
2026-03-31 $257,075 313,508
2025-12-31 $283,571 301,673
2025-09-30 $313,179 265,407
2025-06-30 $256,562 259,154
2025-03-31 $348,868 258,422
2024-12-31 $420,305 240,175
2024-09-30 $249,781 240,175
2024-06-30 $352,921 238,461
2024-03-31 $374,732 224,391
2023-12-31 $358,540 222,696
2023-09-30 $427,576 222,696
2023-06-30 $413,421 214,208
2023-03-31 $381,290 214,208
2022-12-31 $263,475 214,208
2022-09-30 $401,510 210,215
2022-06-30 $641,155 210,215
2022-03-31 $630,002 209,303
2021-12-31 $946,610 209,427
2021-09-30 $1,164,414 209,427
2021-06-30 $636,420 177,276
2021-03-31 $1,812,798 330,200
2020-12-31 $1,631,172 303,192
2020-09-30 $2,251,931 297,481
2020-06-30 $2,533,898 292,598
2020-03-31 $912,511 175,483